K232156 is an FDA 510(k) clearance for the Rapid ASPECTS (v3). This device is classified as a Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer (Class II - Special Controls, product code POK).
Submitted by Ischemaview, Inc. (Golden, US). The FDA issued a Cleared decision on January 19, 2024, 183 days after receiving the submission on July 20, 2023.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2060. Assist Users In Characterizing Lesions Identified On Acquired Medical Images.